242 related articles for article (PubMed ID: 30200932)
1. Could local surgery improve survival in de novo stage IV breast cancer?
Xiong Z; Deng G; Wang J; Li X; Xie X; Shuang Z; Wang X
BMC Cancer; 2018 Sep; 18(1):885. PubMed ID: 30200932
[TBL] [Abstract][Full Text] [Related]
2. Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
Si Y; Yuan P; Hu N; Wang X; Ju J; Wang J; Ma F; Luo Y; Zhang P; Li Q; Xu B
Ann Surg Oncol; 2020 Apr; 27(4):1025-1033. PubMed ID: 31970572
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
[TBL] [Abstract][Full Text] [Related]
4. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
Wang K; Shi Y; Li ZY; Xiao YL; Li J; Zhang X; Li HY
Eur J Surg Oncol; 2019 Aug; 45(8):1364-1372. PubMed ID: 30837102
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
[TBL] [Abstract][Full Text] [Related]
6. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
[TBL] [Abstract][Full Text] [Related]
7. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
[TBL] [Abstract][Full Text] [Related]
8. Local-regional radiotherapy and surgery is associated with a significant survival advantage in metastatic breast cancer patients.
Ly BH; Vlastos G; Rapiti E; Vinh-Hung V; Nguyen NP
Tumori; 2010; 96(6):947-54. PubMed ID: 21388057
[TBL] [Abstract][Full Text] [Related]
9. [Local recurrence based on size after conservative surgery in breast cancer stage T1-T2. A population-based study].
Martínez-Ramos D; Fortea-Sanchis C; Escrig-Sos J; Prats-de Puig M; Queralt-Martín R; Salvador-Sanchis JL
Cir Cir; 2014; 82(3):252-61. PubMed ID: 25238466
[TBL] [Abstract][Full Text] [Related]
10. Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
Kim HJ; Kang E; Kim JH; Kim SH; Kim YJ; Kim IA; Eom KY; Chae SM; Kang KM; Kim EK; Kim SW
Clin Breast Cancer; 2018 Oct; 18(5):e1037-e1044. PubMed ID: 29909259
[TBL] [Abstract][Full Text] [Related]
11. Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
Lane WO; Thomas SM; Blitzblau RC; Plichta JK; Rosenberger LH; Fayanju OM; Hyslop T; Hwang ES; Greenup RA
Ann Surg; 2019 Mar; 269(3):537-544. PubMed ID: 29227346
[TBL] [Abstract][Full Text] [Related]
12. Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery.
Yoo TK; Chae BJ; Kim SJ; Lee J; Yoon TI; Lee SJ; Park HY; Park HK; Eom YH; Kim HS; Kim CJ; Shin MS; You SH; Song BJ
Breast Cancer Res Treat; 2017 Aug; 165(1):109-118. PubMed ID: 28573447
[TBL] [Abstract][Full Text] [Related]
13. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.
den Brok WD; Speers CH; Gondara L; Baxter E; Tyldesley SK; Lohrisch CA
Breast Cancer Res Treat; 2017 Feb; 161(3):549-556. PubMed ID: 28000014
[TBL] [Abstract][Full Text] [Related]
14. Metastatic breast cancer: Who benefits from surgery?
Marks CE; Thomas SM; Fayanju OM; DiLalla G; Sammons S; Hwang ES; Plichta JK
Am J Surg; 2022 Jan; 223(1):81-93. PubMed ID: 34325907
[TBL] [Abstract][Full Text] [Related]
15. Surgery of the primary tumor does not improve survival in stage IV breast cancer.
Dominici L; Najita J; Hughes M; Niland J; Marcom P; Wong YN; Carter B; Javid S; Edge S; Burstein H; Golshan M
Breast Cancer Res Treat; 2011 Sep; 129(2):459-65. PubMed ID: 21713372
[TBL] [Abstract][Full Text] [Related]
16. Survival differences among women with de novo stage IV and relapsed breast cancer.
Dawood S; Broglio K; Ensor J; Hortobagyi GN; Giordano SH
Ann Oncol; 2010 Nov; 21(11):2169-2174. PubMed ID: 20427349
[TBL] [Abstract][Full Text] [Related]
17. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
Bafford AC; Burstein HJ; Barkley CR; Smith BL; Lipsitz S; Iglehart JD; Winer EP; Golshan M
Breast Cancer Res Treat; 2009 May; 115(1):7-12. PubMed ID: 18581232
[TBL] [Abstract][Full Text] [Related]
18. Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.
Shen T; Gao C; Zhang K; Siegal GP; Wei S
Hum Pathol; 2017 Dec; 70():70-76. PubMed ID: 29031733
[TBL] [Abstract][Full Text] [Related]
19. De-novo metastatic breast cancers with or without primary tumor resection - A 10-year study.
Co M; Ng J; Kwong A
Cancer Treat Res Commun; 2019; 19():100118. PubMed ID: 30825858
[TBL] [Abstract][Full Text] [Related]
20. Does aggressive local therapy improve survival in metastatic breast cancer?
Khan SA; Stewart AK; Morrow M
Surgery; 2002 Oct; 132(4):620-6; discussion 626-7. PubMed ID: 12407345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
